<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Arthur Levinson</title>
 <link>http://www.fiercepharma.com/tags/arthur-levinson</link>
 <description></description>
 <language>en</language>
<item>
 <title>Who are pharma&#039;s true VIPs?</title>
 <link>http://www.fiercepharma.com/story/who-are-pharmas-true-vips/2008-05-23?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;You mean&amp;nbsp;you don&#039;t know? Helpfully, a trade magazine has ranked them for you. The&amp;nbsp;40 most influential people in pharma--and they&#039;re not always the people you&#039;d expect. In fact, FDA Commissioner &lt;a href=&quot;http://www.fiercepharma.com/tags/andrew-von-eschenbach&quot;&gt;Andy von Eschenbach&lt;/a&gt;&amp;nbsp;didn&#039;t make the list. Who did? &lt;a href=&quot;http://www.fiercebiotech.com/tags/carl-icahn&quot;&gt;Carl Icahn&lt;/a&gt;, for one. The highest ranking CEO was (drum roll, please) Genentech&#039;s &lt;a href=&quot;http://www.fiercebiotech.com/special-reports/genentech-ceo-arthur-levinson-ceo-pay-report&quot;&gt;Arthur Levinson&lt;/a&gt;&amp;nbsp;at the number two spot.&amp;nbsp;GlaxoSmithKline&#039;s new CEO &lt;a href=&quot;http://www.fiercepharma.com/story/gsk-taps-witty-next-ceo/2007-10-08&quot;&gt;Andrew Witty&lt;/a&gt;&amp;nbsp;came in came in at number six. Other familiar names include &lt;a href=&quot;http://www.fiercebiotech.com/story/gates-foundation-restructures-refocuses/2006-12-01&quot;&gt;Bill and Melinda Gates&lt;/a&gt;&amp;nbsp;(3), &lt;a href=&quot;http://www.fiercepharma.com/story/fda-chief-woodcock-is-a-change-agent-/2008-03-18&quot;&gt;Janet Woodcock&lt;/a&gt;&amp;nbsp;(18), &lt;a href=&quot;http://www.fiercebiotech.com/story/whats-warren-buffett-buying-now/2007-08-17&quot;&gt;Warren Buffett&lt;/a&gt;&amp;nbsp;(25)and &lt;a href=&quot;http://www.fiercebioresearcher.com/story/venter-s-latest-revelation-could-save-the-world/2007-07-03&quot;&gt;J. Craig Venter&lt;/a&gt;&amp;nbsp;(27). You&#039;ll have to read the list to get the rest.&lt;/p&gt;
&lt;p&gt;- check out the&amp;nbsp;&lt;a href=&quot;http://www.worldpharmaceuticals.net/pdfs/pharma40-2008.pdf&quot;&gt;list&lt;/a&gt; and article in &lt;em&gt;World Pharmaceuticals&lt;/em&gt; (.pdf)&lt;br /&gt;- see the &lt;em&gt;Pharmalot&lt;/em&gt;&amp;nbsp;&lt;a href=&quot;http://www.pharmalot.com/2008/05/who-are-the-most-influential-people-in-pharma/&quot;&gt;item&lt;/a&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Related Articles:&lt;br /&gt;&lt;/strong&gt;&lt;a href=&quot;http://www.fiercepharma.com/special-reports/top-17-paychecks-big-pharma&quot;&gt;Top 17 Paychecks in Big Pharma&lt;/a&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fiercebiotech.com/special-reports/ceo-pay-who-makes-what-big-biotech&quot;&gt;CEO pay: Who makes what in Big Biotech?&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.fiercepharma.com/story/who-are-pharmas-true-vips/2008-05-23#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/andrew-witty">Andrew Witty</category>
 <category domain="http://www.fiercepharma.com/tags/arthur-levinson">Arthur Levinson</category>
 <category domain="http://www.fiercepharma.com/tags/bill-and-melinda-gates">Bill And Melinda Gates</category>
 <category domain="http://www.fiercepharma.com/tags/carl-icahn">Carl Icahn</category>
 <category domain="http://www.fiercepharma.com/tags/ceo-pay">CEO pay</category>
 <category domain="http://www.fiercepharma.com/tags/fda">FDA</category>
 <category domain="http://www.fiercepharma.com/tags/genentech">Genentech</category>
 <category domain="http://www.fiercepharma.com/tags/glaxosmithkline">GlaxoSmithKline</category>
 <category domain="http://www.fiercepharma.com/tags/j-craig-venter">J Craig Venter</category>
 <category domain="http://www.fiercepharma.com/tags/janet-woodcock">Janet Woodcock</category>
 <category domain="http://www.fiercepharma.com/tags/von-eschenbach">Von Eschenbach</category>
 <category domain="http://www.fiercepharma.com/tags/warren-buffett">Warren Buffett</category>
 <pubDate>Fri, 23 May 2008 10:57:38 -0400</pubDate>
 <dc:creator>Tracy Staton</dc:creator>
 <guid isPermaLink="false">9074 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>SPOTLIGHT:  Abbott edges Genentech in CEO tourney</title>
 <link>http://www.fiercepharma.com/story/spotlight-abbott-edges-genentech-in-ceo-tourney/2008-04-09?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;
Remember the &lt;a href=&quot;http://www.fiercepharma.com/story/spotlight-who-s-the-best-ceo-of-them-all/2008-03-19&quot;&gt;Pharma CEO tournament bracket&lt;/a&gt; the &lt;em&gt;Wall Street Journal Health Blog&lt;/em&gt; came up with a few weeks ago? Well, the competition was fierce, but the predictions are in. The chosen winner? Miles White (&lt;a href=&quot;http://www.fiercebiotech.com/pages/abbott-ceo-miles-white&quot;&gt;photo&lt;/a&gt;), CEO of Abbott Labs, who won by a nose over Genentech CEO Art Levinson (&lt;a href=&quot;http://www.fiercebiotech.com/pages/genentech-ceo-arthur-levinson&quot;&gt;photo&lt;/a&gt;). White got 40 percent of 12,000 votes compared with Levinson&#039;s 39 percent. &lt;a href=&quot;http://blogs.wsj.com/health/2008/04/08/ceo-survival-abbotts-white-edges-genentechs-levinson/?mod=WSJBlog&quot;&gt;Report&lt;/a&gt;
&lt;/p&gt;
</description>
 <comments>http://www.fiercepharma.com/story/spotlight-abbott-edges-genentech-in-ceo-tourney/2008-04-09#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/abbott">Abbott</category>
 <category domain="http://www.fiercepharma.com/tags/arthur-levinson">Arthur Levinson</category>
 <category domain="http://www.fiercepharma.com/tags/genentech">Genentech</category>
 <category domain="http://www.fiercepharma.com/tags/miles-white">Miles White</category>
 <pubDate>Wed, 09 Apr 2008 06:59:52 -0400</pubDate>
 <dc:creator />
 <guid isPermaLink="false">8813 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
